000 | 01125 a2200325 4500 | ||
---|---|---|---|
005 | 20250518101314.0 | ||
264 | 0 | _c20210906 | |
008 | 202109s 0 0 eng d | ||
022 | _a1476-5462 | ||
024 | 7 |
_a10.1038/s41434-020-0153-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAli, Gibran | |
245 | 0 | 0 |
_aAdvances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment. _h[electronic resource] |
260 |
_bGene therapy _c02 2021 |
||
300 |
_a6-15 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aCRISPR-Cas Systems |
650 | 0 | 4 | _aGene Editing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTechnology |
650 | 0 | 4 |
_abeta-Globins _xgenetics |
650 | 0 | 4 |
_abeta-Thalassemia _xgenetics |
700 | 1 | _aTariq, Muhammad Akram | |
700 | 1 | _aShahid, Kamran | |
700 | 1 | _aAhmad, Fridoon Jawad | |
700 | 1 | _aAkram, Javed | |
773 | 0 |
_tGene therapy _gvol. 28 _gno. 1-2 _gp. 6-15 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41434-020-0153-9 _zAvailable from publisher's website |
999 |
_c30920897 _d30920897 |